Drug Trial Radar · NCT06215820
Study of MR-107A-02 for the Treatment of Acute Postoperative Pain Following Bunionectomy
Last checked: Nov 20, 2026Latest source record: Oct 14, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
410
Actual
Start
Dec 29, 2023
Primary completion
Aug 24, 2024
Study completion Sep 30, 2024
Sponsor
- Lead sponsor
- Viatris Specialty LLCIndustry
- Sponsor type
- Industry
- Collaborators
- Mylan Specialty, LP
- First posted
- Jan 22, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
MR-107A-02 is being studied to investigate its efficacy and safety for treatment of acute pain after bunionectomy.
Conditions
- Acute Pain
- Post Operative Pain
- Pain
Interventions
MR-107A-02Drug
tablet
TramadolDrug
over-encapsulated tablet
PlaceboDrug
over-encapsulated tablet and/or tablet
BunionectomyProcedure
Primary unilateral bunionectomy with first metatarsal osteotomy under regional anesthesia
Primary outcomes
What the sponsor says the trial is designed to measure.
- Summed Pain Intensity Difference (SPID) for MR-107A-02 versus placebo.Time frame: 48 hours after randomization
Locations
15 sites in 1 country. Site status is shown where the registry gives one.
Investigator site 114
Sheffield, Alabama
Investigator site 115
Phoenix, Arizona
Investigator site 103
Anaheim, California
Investigator site 110
Riverside, California
Investigator site 112
Miami, Florida
Investigator site 108
Tampa, Florida
Investigator site 109
Atlanta, Georgia
Investigator site 104
O'Fallon, Illinois
Investigator site 102
Pasadena, Maryland
Investigator site 113
Bellaire, Texas
Investigator site 107
Carrollton, Texas
Investigator site 106
Houston, Texas
Investigator site 111
McAllen, Texas
Investigator site 105
San Antonio, Texas
Investigator site 101
Salt Lake City, Utah
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.